Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 2493
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Spirovet 600000 IU/ml V/MRP/12/0056 Ceva Sante Animale', Francija QJ01FA02 cattle Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Spiramycin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva Sante Animale., Francija
Date of authorisation/renewal: 30-Nov-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Dec-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Dec-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/12/0056-01 600000 IU/ml 1 Stikla flakons, 50 ml -
V/MRP/12/0056-02 600000 IU/ml 1 Stikla flakons, 100 ml -
V/MRP/12/0056-03 600000 IU/ml 1 Stikla flakons, 250 ml -
V/MRP/12/0056-04 600000 IU/ml 1 Plastmasas pudele, 50 ml -
V/MRP/12/0056-05 600000 IU/ml 1 Plastmasas pudele, 100 ml -
V/MRP/12/0056-06 600000 IU/ml 1 Plastmasas pudele, 250 ml -
Prinocate 40 mg/4 mg - V/DCP/20/0005 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 ferrets; small cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0005-01 40/4 1 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0005-02 40/4 3 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0005-03 40/4 4 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0005-04 40/4 6 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0005-05 40/4 24 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0005-06 40/4 48 Polipropilēna pipete, 0,4 ml -
Prinocate 80 mg/8 mg - V/DCP/20/0006 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 large cats Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0006-01 80/8 mg 1 Polipropilēna pipete, 0,8 ml -
V/DCP/20/0006-02 80/8 mg 3 Polipropilēna pipete, 0,8 ml -
V/DCP/20/0006-03 80/8 mg 4 Polipropilēna pipete, 0,8 ml -
V/DCP/20/0006-04 80/8 mg 6 Polipropilēna pipete, 0,8 ml -
V/DCP/20/0006-05 80/8 mg 24 Polipropilēna pipete, 0,8 ml -
V/DCP/20/0006-06 80/8 mg 48 Polipropilēna pipete, 0,8 ml -
Prinocate 40 mg/10 mg - V/DCP/20/0007 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 small dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0007-01 40/10 mg 1 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0007-02 40/10 mg 3 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0007-03 40/10 mg 4 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0007-04 40/10 mg 6 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0007-05 40/10 mg 24 Polipropilēna pipete, 0,4 ml -
V/DCP/20/0007-06 40/10 mg 48 Polipropilēna pipete, 0,4 ml -
Prinocate 100 mg/25 mg - V/DCP/20/0008 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 medium dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0008-01 100/25 mg 1 Polipropilēna pipete, 1 ml -
V/DCP/20/0008-02 100/25 mg 3 Polipropilēna pipete, 1 ml -
V/DCP/20/0008-03 100/25 mg 4 Polipropilēna pipete, 1 ml -
V/DCP/20/0008-04 100/25 mg 6 Polipropilēna pipete, 1 ml -
V/DCP/20/0008-05 100/25 mg 24 Polipropilēna pipete, 1 ml -
V/DCP/20/0008-06 100/25 mg 48 Polipropilēna pipete, 1 ml -
Prinocate 250 mg/62,5 mg - V/DCP/20/0009 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0009-01 250/62,5 mg 1 Polipropilēna pipete, 2,5 ml -
V/DCP/20/0009-02 250/62,5 mg 3 Polipropilēna pipete, 2,5 ml -
V/DCP/20/0009-03 250/62,5 mg 4 Polipropilēna pipete, 2,5 ml -
V/DCP/20/0009-04 250/62,5 mg 6 Polipropilēna pipete, 2,5 ml -
V/DCP/20/0009-05 250/62,5 mg 24 Polipropilēna pipete, 2,5 ml -
V/DCP/20/0009-06 250/62,5 mg 48 Polipropilēna pipete, 2,5 ml -
Prinocate 400 mg/100 mg - V/DCP/20/0010 KRKA, d.d., Novo mesto, Slovēnija QP54AB52 very large dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 03-Feb-2020
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0010-01 400/100 mg 1 Polipropilēna pipete, 4 ml -
V/DCP/20/0010-02 400/100 mg 3 Polipropilēna pipete, 4 ml -
V/DCP/20/0010-03 400/100 mg 4 Polipropilēna pipete, 4 ml -
V/DCP/20/0010-04 400/100 mg 6 Polipropilēna pipete, 4 ml -
V/DCP/20/0010-05 400/100 mg 24 Polipropilēna pipete, 4 ml -
V/DCP/20/0010-06 400/100 mg 48 Polipropilēna pipete, 4 ml -
Cepedol Vet 20 mg V/DCP/24/0018 CP-Pharma Handelsgesellschaft GmbH, Vācija QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 20-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0018-01 1 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0018-02 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0018-03 5 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0018-04 10 AL/PVC-AL-PA blisteris, 10 tablete -
Cepedol Vet 50 mg V/DCP/24/0019 CP-Pharma Handelsgesellschaft GmbH, Vācija QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 20-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0019-01 1 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0019-02 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0019-03 5 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0019-04 10 AL/PVC-AL-PA blisteris, 10 tablete -
Mexxam Vet 15 mg/ml V/DCP/23/0001 Alfasan Nederland BV, Nīderlande QM01AC06 horses Vairāk

Medicinal product information

Pharmaceutical form: suspension for oral use
International name (active substance): Meloxicam
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande;Alfasan Nederland BV, Nīderlande
Date of authorisation/renewal: 23-Jan-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jan-2023)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (23-Jan-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0001-01 1 Polietilēna pudelīte, 125 ml -
V/DCP/23/0001-02 1 Polietilēna pudelīte, 336 ml -
Cardisan 1.25 mg V/DCP/22/0050 Alfasan Nederland BV, Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Dec-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0050-01 1,25 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0050-02 1,25 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0050-03 1,25 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0050-04 1,25 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0050-05 1,25 mg 12 Al/OPA/Al/PVH blisteris, 10 tablete -
Cardisan 2.5 mg V/DCP/22/0051 Alfasan Nederland BV, Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Dec-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0051-01 2,5 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0051-02 2,5 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0051-03 2,5 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0051-04 2,5 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0051-05 2,5 mg 12 Al/OPA/Al/PVH blisteris, 10 tablete -
Cardisan 5 mg V/DCP/22/0052 Alfasan Nederland BV, Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Dec-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0052-01 5 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0052-02 5 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0052-03 5 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0052-04 5 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0052-05 5 mg 12 Al/OPA/Al/PVH blisteris, 10 tablete -
Cardisan 10 mg V/DCP/22/0053 Alfasan Nederland BV, Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Dec-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0053-01 10 mg 3 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0053-02 10 mg 6 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0053-03 10 mg 9 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0053-04 10 mg 10 Al/OPA/Al/PVH blisteris, 10 tablete -
V/DCP/22/0053-05 10 mg 12 Al/OPA/Al/PVH blisteris, 10 tablete -
Cardisan 15 mg V/DCP/22/0054 Alfasan Nederland BV, Nīderlande QC01CE90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Pimobendan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 19-Dec-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (19-Dec-2022)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (19-Dec-2022)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0054-01 15 mg 6 Al/OPA/Al/PVH blisteris, 5 tablete -
V/DCP/22/0054-02 15 mg 12 Al/OPA/Al/PVH blisteris, 5 tablete -
V/DCP/22/0054-03 15 mg 18 Al/OPA/Al/PVH blisteris, 5 tablete -
V/DCP/22/0054-04 15 mg 20 Al/OPA/Al/PVH blisteris, 5 tablete -
V/DCP/22/0054-05 15 mg 24 Al/OPA/Al/PVH blisteris, 5 tablete -
Ceftiosan 50 mg/ml V/DCP/12/0003 Alfasan Nederland BV, Nīderlande QJ01DD90 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Ceftiofur (as ceftiofur hydrochloride)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande
Date of authorisation/renewal: 07-Mar-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] 200317LI (22-Mar-2017)
Labelling text: [PDF] 200317M (22-Mar-2017)
Summary of product characteristics: [PDF] 200317ZA (22-Mar-2017)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/12/0003-01 50 mg/ml 1 Stikla flakons, 100 ml -
V/DCP/12/0003-02 50 mg/ml 12 Stikla flakons, 100 ml -
V/DCP/12/0003-03 50 mg/ml 1 Stikla flakons, 250 ml -
V/DCP/12/0003-04 50 mg/ml 6 Stikla flakons, 250 ml -
V/DCP/12/0003-05 50 mg/ml 1 Stikla flakons, 50 ml -
V/DCP/12/0003-06 50 mg/ml 15 Stikla flakons, 50 ml -
Nobivac Respira Bb - V/DCP/20/0055 Intervet International B.V., Nīderlande QI07AB03 dogs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection in pre-filled syringes
International name (active substance): Bordetella bronchiseptica fimbriae
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Feb-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Feb-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (27-Feb-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0055-01 5 Stikla pilnšļirce, 1 deva -
V/DCP/20/0055-02 10 Stikla pilnšļirce, 1 deva -
Nobivac Respira Bb - V/DCP/20/0056 Intervet International B.V., Nīderlande QI07AB03 dogs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Bordetella bronchiseptica fimbriae
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Feb-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Feb-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (27-Feb-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/20/0056-01 1 Polietilēna flakons, 10 deva -
Exitel Plus - V/MRP/09/0028 Chanelle Pharmaceuticals Manufacturing Ltd., Īrija QP52AA51 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Febantel,Praziquantel,Pyrantel embonate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 08-Apr-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-May-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-May-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/09/0028-01 2 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-02 4 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-03 6 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-04 8 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-05 10 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-06 12 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-07 14 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-08 16 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-09 18 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-10 20 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-11 24 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-12 28 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-13 30 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-14 32 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-15 36 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-16 40 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-17 42 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-18 44 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-19 48 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-20 50 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-21 52 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-22 56 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-23 60 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-24 70 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-25 80 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-26 84 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-27 90 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-28 98 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-29 100 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-30 104 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-31 106 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-32 120 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-33 140 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-34 150 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-35 180 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-36 200 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-37 204 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-38 206 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-39 250 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-40 280 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-41 300 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-42 500 Alumīnija blisteris, 1 tablete -
V/MRP/09/0028-43 1000 Alumīnija blisteris, 1 tablete -
Cepedol Vet 80 mg V/DCP/24/0020 CP-Pharma Handelsgesellschaft GmbH, Vācija QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 20-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0020-01 1 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0020-02 3 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0020-03 5 AL/PVC-AL-PA blisteris, 10 tablete -
V/DCP/24/0020-04 10 AL/PVC-AL-PA blisteris, 10 tablete -

3080 records

© Food and veterinary service · 2026 Cookies policy